IFNGR1, a key molecule in the interferon signaling pathway, activates macrophages and promotes Th1-mediated inflammatory responses, and the knockdown of IFNGR1 in mouse models has been associated with recovery from immune dysfunction and an increase in Tregs cells [58,59]. This evidence concerns the gene IFNGR1 and immune system disorder.